Liquidia (NASDAQ:LQDA) CFO Michael Kaseta Sells 20,430 Shares of Stock

Liquidia Corporation (NASDAQ:LQDA) CFO Michael Kaseta sold 20,430 shares of the stock in a transaction dated Monday, July 13th. The stock was sold at an average price of $71.51, for a total transaction of $1,460,949.30. Following the sale, the chief financial officer directly owned 345,805 shares in the company, valued at approximately $24,728,515.55. The trade was a 5.58% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Michael Kaseta also recently made the following trade(s):

• On Wednesday, April 15th, Michael Kaseta sold 139,390 shares of Liquidia stock. The shares were sold at an average price of $40.14, for a total value of $5,595,114.60.

Liquidia Price Performance

NASDAQ LQDA traded up $5.28 during trading hours on Tuesday, reaching $76.49. The company’s stock had a trading volume of 1,153,916 shares, compared to its average volume of 2,219,263. The firm has a market capitalization of $6.80 billion, a price-to-earnings ratio of 546.40 and a beta of 0.55. Liquidia Corporation has a 1-year low of $14.04 and a 1-year high of $82.96. The company has a debt-to-equity ratio of 1.18, a current ratio of 2.22 and a quick ratio of 2.03. The company’s 50-day moving average is $66.37 and its two-hundred day moving average is $47.52.

Liquidia (NASDAQ:LQDA) last issued its quarterly earnings results on Monday, May 11th. The company reported $0.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.41 by $0.11. Liquidia had a return on equity of 46.82% and a net margin of 7.74%.The company had revenue of $132.87 million for the quarter, compared to the consensus estimate of $119.44 million. The business’s quarterly revenue was up 4187.1% compared to the same quarter last year. On average, equities analysts predict that Liquidia Corporation will post 3.02 EPS for the current year.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on LQDA. Raymond James Financial reissued a “strong-buy” rating and issued a $68.00 price target on shares of Liquidia in a research note on Thursday, June 4th. HC Wainwright upped their price target on shares of Liquidia from $67.00 to $75.00 and gave the stock a “buy” rating in a research report on Friday, June 5th. Oppenheimer set a $75.00 price objective on Liquidia in a report on Friday, June 5th. Bank of America reiterated a “neutral” rating and set a $79.00 price objective (up from $64.00) on shares of Liquidia in a research note on Monday, June 29th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Liquidia in a report on Tuesday, April 21st. Three research analysts have rated the stock with a Strong Buy rating, five have given a Buy rating, one has given a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, Liquidia currently has a consensus rating of “Moderate Buy” and an average target price of $68.88.

Institutional Trading of Liquidia

A number of hedge funds have recently bought and sold shares of LQDA. GSA Capital Partners LLP grew its position in shares of Liquidia by 63.6% in the fourth quarter. GSA Capital Partners LLP now owns 63,176 shares of the company’s stock valued at $2,179,000 after purchasing an additional 24,555 shares in the last quarter. Farallon Capital Management LLC lifted its position in Liquidia by 102.1% during the third quarter. Farallon Capital Management LLC now owns 8,565,638 shares of the company’s stock worth $194,783,000 after buying an additional 4,326,876 shares in the last quarter. Tudor Investment Corp ET AL acquired a new position in Liquidia during the third quarter worth $1,536,000. State of New Jersey Common Pension Fund D acquired a new position in Liquidia during the fourth quarter worth $709,000. Finally, WCG Wealth Advisors LLC grew its holdings in Liquidia by 98.2% in the 4th quarter. WCG Wealth Advisors LLC now owns 54,411 shares of the company’s stock valued at $1,877,000 after buying an additional 26,957 shares in the last quarter. Institutional investors and hedge funds own 64.54% of the company’s stock.

Liquidia Company Profile

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).